Texas 2013 - 83rd Regular

Texas House Bill HB1381

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to prohibiting the delivery of prescription drug benefits under the Medicaid program through a managed care delivery model.

Impact

The implications of HB 1381 could lead to significant shifts in how prescription drug benefits are administered within Texas's Medicaid program. By excluding these benefits from managed care contracts, the bill aligns more closely with a fee-for-service model. This approach may lead to increased scrutiny and assurance regarding the quality of drug prescription services, potentially benefiting recipients who require access to necessary medications. However, it could also disrupt the operational model of managed care organizations tasked with providing healthcare under the Medicaid program.

Summary

House Bill 1381 seeks to amend the delivery of prescription drug benefits under the Texas Medicaid program by prohibiting the use of a managed care delivery model. The bill asserts that prescription drug benefits should not be incorporated into the managed care contracts that Medicaid utilizes, essentially reverting to a more traditional model for the provision of these services. The intent is to improve oversight and reduce any potential for mismanagement that might arise from integrating prescription benefits into managed care arrangements.

Sentiment

The sentiment surrounding HB 1381 appears to vary among stakeholders. Proponents, particularly some health care advocates and policymakers, argue that removing prescription medications from managed care ensures that patients receive better-focused care, free from potential conflicts of interest inherent in profit-driven models. Conversely, opponents raise concerns over the possible fragmentation of care and increased complexity in accessing necessary prescriptions, fearing that this could lead to delays in medication delivery for vulnerable populations reliant on Medicaid.

Contention

Key points of contention regarding HB 1381 center around the balance between cost-effectiveness and quality care. Opponents of the bill argue that the existing managed care model facilitates better integration of healthcare services and may ultimately lead to improved health outcomes for patients. Consequently, the bill represents a departure from established practices that many believe could lead to reduced efficiency and increased operational challenges within the healthcare system. The divisive nature of this issue reflects broader debates on healthcare reform, particularly the role of managed care in public health programs.

Companion Bills

TX SB450

Identical Relating to prohibiting the delivery of prescription drug benefits under the Medicaid program through a managed care delivery model.

Similar Bills

TX SB1416

Relating to certain contracts between pharmacy benefit managers and the Employees Retirement System of Texas, the Teacher Retirement System of Texas, The Texas A&M University System, or The University of Texas System.

AR SB593

To Amend The Arkansas Pharmacy Benefits Manager Licensure Act; And To Create The Pharmacy Services Administrative Organization Act.

TX SB1236

Relating to the relationship between pharmacists or pharmacies and health benefit plan issuers or pharmacy benefit managers.

AR SB544

To Amend The Arkansas Pharmacy Benefits Manager Licensure Act.

TX HB1763

Relating to the contractual relationship between a pharmacist or pharmacy and a health benefit plan issuer or pharmacy benefit manager.

TX SB528

Relating to the contractual relationship between a pharmacist or pharmacy and a health benefit plan issuer or pharmacy benefit manager.

TX HB1670

Relating to the contractual relationship between a pharmacist or pharmacy and a health benefit plan issuer or pharmacy benefit manager.

TX HB2817

Relating to the contractual relationship between a pharmacist or pharmacy and a health benefit plan issuer or pharmacy benefit manager.